Related Experiment Videos

Treatment of hypertension in patients with congestive cardiac failure

Nisha B Mistry1, Arne S Westheim, Sverre E Kjeldsen

  • 1Department of Cardiology, University of Oslo Ullevaal Hospital, Oslo, Norway.

Heart Failure Monitor
|July 4, 2006
PubMed

Insights

Hypertension significantly increases cardiac failure risk. Current hypertension trials often exclude patients with severe heart failure, despite European guidelines recommending blood pressure management for these individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Hypertension is a primary risk factor for cardiac failure development.
  • Patients with severe heart failure (left ventricular ejection fraction <40%) are frequently excluded from hypertension clinical trials.
  • Effective blood pressure management is crucial for patients with co-existing heart failure.

Purpose of the Study:

  • To highlight the importance of treating hypertension in heart failure patients.
  • To emphasize the need for guideline-adherent blood pressure management in severe heart failure.
  • To discuss therapeutic strategies for achieving target blood pressure in this population.

Main Methods:

  • Review of European Society of Cardiology (ESC) guidelines on hypertension and heart failure management.
  • Analysis of patient populations typically included in hypertension trials.
  • Discussion of pharmacological approaches for blood pressure control in heart failure.

Main Results:

  • Severe heart failure patients are underrepresented in hypertension research.
  • European Guidelines advocate for treating hypertension in heart failure patients.
  • Combination therapy is often necessary to reach target blood pressure goals.

Conclusions:

  • Aggressive blood pressure management is recommended for heart failure patients.
  • Current trial exclusions limit evidence for optimal hypertension treatment in severe heart failure.
  • Multidrug regimens are frequently required to effectively manage hypertension in this vulnerable group.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...